Jinhe Biotechnology CO., LTD. (SHE:002688)
China · Delayed Price · Currency is CNY 5.20
+0.06 (1.17%)
Sep 30, 2026, 3:04 PM CST
SHE:002688 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 700.09 | 618.35 | 635.89 | 608.13 | 491.37 | 517.66 |
Trading Asset Securities | 0.98 | 1.38 | 0.55 | 0.51 | - | - |
Cash & Short-Term Investments | 701.07 | 619.74 | 636.45 | 608.64 | 491.37 | 517.66 |
Cash Growth | 11.92% | -2.63% | 4.57% | 23.87% | -5.08% | 64.44% |
Accounts Receivable | 613.76 | 656.18 | 659.9 | 633.13 | 504.86 | 493.6 |
Other Receivables | 58.89 | 46.16 | 16.53 | 64.79 | 12.12 | 11.22 |
Receivables | 672.64 | 702.34 | 676.43 | 697.92 | 516.98 | 504.82 |
Inventory | 774.9 | 668.1 | 635.28 | 670.55 | 675.91 | 577.2 |
Prepaid Expenses | 1.69 | 1.85 | 0.23 | 0.2 | 0.25 | 0.31 |
Other Current Assets | 79.08 | 65.81 | 72.32 | 62.27 | 62.01 | 49.97 |
Total Current Assets | 2,229 | 2,058 | 2,021 | 2,040 | 1,747 | 1,650 |
Property, Plant & Equipment | 2,365 | 2,370 | 2,322 | 2,052 | 1,623 | 1,209 |
Long-Term Investments | 12.15 | 17.16 | 17.16 | 12.16 | 3.15 | 0.53 |
Goodwill | 277.75 | 282.11 | 460.3 | 497.95 | 298.91 | 295.97 |
Other Intangible Assets | 619.42 | 631.15 | 639.94 | 656.4 | 629.72 | 645.33 |
Long-Term Deferred Tax Assets | 51.89 | 50.77 | 71.21 | 50.05 | 16.54 | 9.99 |
Long-Term Deferred Charges | 62.64 | 75.43 | 92.12 | 102.43 | 88.32 | 75.35 |
Other Long-Term Assets | 46.57 | 34.9 | 27.03 | 42.98 | 102.16 | 178.59 |
Total Assets | 5,665 | 5,519 | 5,651 | 5,454 | 4,509 | 4,065 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 267.58 | 298.57 | 313.71 | 254.91 | 263.11 | 122.04 |
Accrued Expenses | 90.74 | 52.06 | 72.84 | 99.62 | 47.4 | 36.65 |
Short-Term Debt | 577.16 | 730.35 | 1,032 | 1,687 | 1,246 | 833.9 |
Current Portion of Long-Term Debt | 557.74 | 465.81 | 225.37 | 82.31 | 44.79 | 85.24 |
Current Portion of Leases | 247.17 | 116.95 | 75.82 | 7.13 | 6.56 | 1.95 |
Current Income Taxes Payable | 23.37 | 3.23 | 21.97 | 1.1 | 1.23 | 5.21 |
Current Unearned Revenue | 17.54 | 24.74 | 17.96 | 17.77 | 25.66 | 30.61 |
Other Current Liabilities | 112.24 | 110.46 | 101.16 | 107.78 | 29.42 | 48.08 |
Total Current Liabilities | 1,894 | 1,802 | 1,861 | 2,257 | 1,665 | 1,164 |
Long-Term Debt | 967.31 | 992.34 | 965.79 | 497.49 | 296.22 | 87 |
Long-Term Leases | 146.75 | 113.01 | 154.64 | 26.19 | 7.67 | - |
Long-Term Unearned Revenue | 63.26 | 59.09 | 56.12 | 39.24 | 38.09 | 38.33 |
Long-Term Deferred Tax Liabilities | 106.03 | 108.99 | 112.97 | 116.88 | 76.6 | 67.38 |
Other Long-Term Liabilities | 0.97 | - | - | - | - | 11.64 |
Total Liabilities | 3,178 | 3,076 | 3,151 | 2,937 | 2,083 | 1,368 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 769.5 | 769.53 | 771.69 | 780.42 | 780.42 | 780.42 |
Additional Paid-In Capital | 879.78 | 875.99 | 879.51 | 896.48 | 888.96 | 1,079 |
Retained Earnings | 723.61 | 668.29 | 715.52 | 690.64 | 679.56 | 603.94 |
Treasury Stock | -94.16 | -94.28 | -138.86 | -131.89 | -131.89 | - |
Comprehensive Income & Other | -7.69 | 8.87 | 18.75 | 11.14 | 4.61 | -25.2 |
Total Common Equity | 2,271 | 2,228 | 2,247 | 2,247 | 2,222 | 2,438 |
Minority Interest | 215.77 | 214.94 | 253.25 | 269.89 | 203.63 | 258.28 |
Shareholders' Equity | 2,487 | 2,443 | 2,500 | 2,517 | 2,425 | 2,696 |
Total Liabilities & Equity | 5,665 | 5,519 | 5,651 | 5,454 | 4,509 | 4,065 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 2,496 | 2,418 | 2,454 | 2,300 | 1,602 | 1,008 |
Net Cash (Debt) | -1,795 | -1,799 | -1,818 | -1,691 | -1,110 | -490.44 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -2.30 | -2.30 | -2.35 | -2.17 | -1.42 | -0.70 |
Filing Date Shares Outstanding | 755.68 | 755.68 | 752.17 | 753.75 | 753.75 | 780.42 |
Total Common Shares Outstanding | 755.68 | 755.71 | 752.17 | 753.75 | 753.75 | 780.42 |
Working Capital | 335.84 | 255.66 | 159.49 | -217.74 | 81.88 | 486.27 |
Book Value Per Share | 3.01 | 2.95 | 2.99 | 2.98 | 2.95 | 3.12 |
Tangible Book Value | 1,374 | 1,315 | 1,146 | 1,092 | 1,293 | 1,497 |
Tangible Book Value Per Share | 1.82 | 1.74 | 1.52 | 1.45 | 1.72 | 1.92 |
Buildings | 1,259 | 1,262 | 1,204 | 918.97 | 806.47 | 671.81 |
Machinery | 2,337 | 2,249 | 2,032 | 1,586 | 1,515 | 1,145 |
Construction In Progress | 282.86 | 195.5 | 246.27 | 645.56 | 300.79 | 289.91 |